Molecular  ||| S:0 E:10 ||| JJ
epidemiological  ||| S:10 E:26 ||| JJ
analysis  ||| S:26 E:35 ||| NN
of  ||| S:35 E:38 ||| IN
the  ||| S:38 E:42 ||| DT
HIV  ||| S:42 E:46 ||| NNP
infection  ||| S:46 E:56 ||| NN
in  ||| S:56 E:59 ||| IN
the  ||| S:59 E:63 ||| DT
Blagoveshchensk  ||| S:63 E:79 ||| NNP
and  ||| S:79 E:83 ||| CC
Khabarovsk  ||| S:83 E:94 ||| NNP
Area  ||| S:94 E:99 ||| NNP
( ||| S:99 E:100 ||| -LRB-
Russian  ||| S:100 E:108 ||| NNP
Far  ||| S:108 E:112 ||| NNP
East ||| S:112 E:116 ||| NNP
)  ||| S:116 E:118 ||| -RRB-
The  ||| S:118 E:122 ||| DT
results  ||| S:122 E:130 ||| NNS
of  ||| S:130 E:133 ||| IN
the  ||| S:133 E:137 ||| DT
molecular-epidemiological  ||| S:137 E:163 ||| JJ
analysis  ||| S:163 E:172 ||| NN
of  ||| S:172 E:175 ||| IN
the  ||| S:175 E:179 ||| DT
HIV-1  ||| S:179 E:185 ||| NNP
variants  ||| S:185 E:194 ||| VBZ
circulating  ||| S:194 E:206 ||| VBG
in  ||| S:206 E:209 ||| IN
Blagoveshchensk  ||| S:209 E:225 ||| NNP
and  ||| S:225 E:229 ||| CC
Khabarovsk  ||| S:229 E:240 ||| NNP
( ||| S:240 E:241 ||| -LRB-
Russian  ||| S:241 E:249 ||| NNP
Far  ||| S:249 E:253 ||| NNP
East ||| S:253 E:257 ||| NNP
)  ||| S:257 E:259 ||| -RRB-
were  ||| S:259 E:264 ||| VBD
presented ||| S:264 E:273 ||| VBN
.  ||| S:273 E:275 ||| .
In  ||| S:275 E:278 ||| IN
Blagoveshchensk  ||| S:278 E:294 ||| NNP
HIV-1  ||| S:294 E:300 ||| NNP
IDU-A  ||| S:300 E:306 ||| JJ
variants  ||| S:306 E:315 ||| NN
were  ||| S:315 E:320 ||| VBD
dominated  ||| S:320 E:330 ||| VBN
( ||| S:330 E:331 ||| -LRB-
92.5 ||| S:331 E:335 ||| NNP
% ||| S:335 E:336 ||| NN
) ||| S:336 E:337 ||| -RRB-
,  ||| S:337 E:339 ||| ,
similar  ||| S:339 E:347 ||| JJ
to  ||| S:347 E:350 ||| TO
the  ||| S:350 E:354 ||| DT
regions  ||| S:354 E:362 ||| NNS
of  ||| S:362 E:365 ||| IN
the  ||| S:365 E:369 ||| DT
European  ||| S:369 E:378 ||| JJ
part  ||| S:378 E:383 ||| NN
of  ||| S:383 E:386 ||| IN
Russia ||| S:386 E:392 ||| NNP
.  ||| S:392 E:394 ||| .
In  ||| S:394 E:397 ||| IN
Khabarovsk  ||| S:397 E:408 ||| NNP
the  ||| S:408 E:412 ||| DT
heterogeneity  ||| S:412 E:426 ||| NN
of  ||| S:426 E:429 ||| IN
circulating  ||| S:429 E:441 ||| VBG
HIV-1  ||| S:441 E:447 ||| CD
variants  ||| S:447 E:456 ||| NNS
was  ||| S:456 E:460 ||| VBD
noted ||| S:460 E:465 ||| VBN
.  ||| S:465 E:467 ||| .
In  ||| S:467 E:470 ||| IN
addition  ||| S:470 E:479 ||| NN
to  ||| S:479 E:482 ||| TO
IDU-A  ||| S:482 E:488 ||| JJ
variants  ||| S:488 E:497 ||| NNS
( ||| S:497 E:498 ||| -LRB-
66.0 ||| S:498 E:502 ||| NNP
% ||| S:502 E:503 ||| NN
) ||| S:503 E:504 ||| -RRB-
,  ||| S:504 E:506 ||| ,
the  ||| S:506 E:510 ||| DT
strains  ||| S:510 E:518 ||| NNS
of  ||| S:518 E:521 ||| IN
subtype  ||| S:521 E:529 ||| JJ
B  ||| S:529 E:531 ||| NNP
( ||| S:531 E:532 ||| -LRB-
12.6 ||| S:532 E:536 ||| CD
% ||| S:536 E:537 ||| NN
) ||| S:537 E:538 ||| -RRB-
,  ||| S:538 E:540 ||| ,
C  ||| S:540 E:542 ||| NNP
( ||| S:542 E:543 ||| -LRB-
4.4 ||| S:543 E:546 ||| CD
% ||| S:546 E:547 ||| NN
)  ||| S:547 E:549 ||| -RRB-
and  ||| S:549 E:553 ||| CC
recombinant  ||| S:553 E:565 ||| JJ
strain  ||| S:565 E:572 ||| NN
form  ||| S:572 E:577 ||| NN
CRF02_AG  ||| S:577 E:586 ||| NNP
( ||| S:586 E:587 ||| -LRB-
17.0 ||| S:587 E:591 ||| NNP
% ||| S:591 E:592 ||| NN
)  ||| S:592 E:594 ||| -RRB-
were  ||| S:594 E:599 ||| VBD
identified ||| S:599 E:609 ||| VBN
.  ||| S:609 E:611 ||| .
Using  ||| S:611 E:617 ||| VBG
the  ||| S:617 E:621 ||| DT
phylogenetic  ||| S:621 E:634 ||| JJ
analysis  ||| S:634 E:643 ||| NN
method  ||| S:643 E:650 ||| NN
the  ||| S:650 E:654 ||| DT
version  ||| S:654 E:662 ||| NN
of  ||| S:662 E:665 ||| IN
the  ||| S:665 E:669 ||| DT
penetration  ||| S:669 E:681 ||| NN
of  ||| S:681 E:684 ||| IN
HIV-1  ||| S:684 E:690 ||| NNP
variants  ||| S:690 E:699 ||| NN
from  ||| S:699 E:704 ||| IN
China  ||| S:704 E:710 ||| NNP
and  ||| S:710 E:714 ||| CC
Japan  ||| S:714 E:720 ||| NNP
was  ||| S:720 E:724 ||| VBD
not  ||| S:724 E:728 ||| RB
supported ||| S:728 E:737 ||| VBN
.  ||| S:737 E:739 ||| .
